Join Date
October 2024
Country
Gender
Not Specified
Age
Not Specified
About Felix Steinbrenner
3 years of experience in Last Mile Delivery Operations at Glocally (W22) where I was responsible for making sure every parcel arrived on time. Currently building Cellbyte, the AI copilot for Pricing&Market Access in pharma.
Companies & Work
Glocally
Cellbyte is an AI copilot that helps pharma companies launch new drugs in different countries. We launched 3 months ago, and companies like Lilly and Gilead are already paying us $200k a year to answer questions like “What price can we achieve for our new drug in the U.S. versus Germany?“.
The right answer heavily depends on data from national healthcare authorities, which must be accurate and comprehensive. One has to first consolidate gigabytes of fragmented, messy and multi-language data from websites and documents scattered across the internet. Prior to LLMs this was nearly impossible and even today it is still difficult without industry knowledge.
Cellbyte instantly turns this data into charts, analyses and reports. By saving pharma companies +$200/hour in analyst fees, we have won enterprise deals against firms with thousands of employees.
Daniel has experienced this pain first-hand working for a leading global Life Sciences consultancy for 5+ years. Felix has sold $3m+ ACV enterprise deals for his previous startup. Samuel has built AI applications from scratch as one of Celonis’ first employees.
The right answer heavily depends on data from national healthcare authorities, which must be accurate and comprehensive. One has to first consolidate gigabytes of fragmented, messy and multi-language data from websites and documents scattered across the internet. Prior to LLMs this was nearly impossible and even today it is still difficult without industry knowledge.
Cellbyte instantly turns this data into charts, analyses and reports. By saving pharma companies +$200/hour in analyst fees, we have won enterprise deals against firms with thousands of employees.
Daniel has experienced this pain first-hand working for a leading global Life Sciences consultancy for 5+ years. Felix has sold $3m+ ACV enterprise deals for his previous startup. Samuel has built AI applications from scratch as one of Celonis’ first employees.
